The market for artificial cornea and corneal implants is expanding due to consumers’ willingness to spend money on eye care. In addition, the prevalence of ophthalmic conditions such as keratoconus, Fuchs dystrophy. And viral keratitis is a major factor in the market’s expansion. Additionally, the global market for artificial corneal implants is growing. Due to increased healthcare costs for eye treatments in developing countries. The demand for novel treatments and the increase in surgical procedures are two more factors that may cause the market to grow.
The market worth of artificial cornea and corneal implants in 2021 was worth USD 421 million. And by 2030 it will be worth USD 767.50 million growing at a 6.9% CAGR during the forecast period.
To replace a particular layer of the cornea. Natural cornea tissue from a donor’s eye is sutured into place using the artificial cornea transplantation technique.
Market Dynamics
Drivers
Factors fostering the market expansion are the rising prevalence of corneal infections and other eye-related conditions among the general population. Additionally, the aging population, which is more vulnerable to these diseases, is driving market expansion. For the prompt treatment of these conditions. And the avoidance of corneal blindness, artificial cornea, and corneal implant operations are widely employed. The growing popularity of penetrating keratoplasty operations is also encouraging market expansion.
Restraints
The global market for artificial cornea implants will be severely constrained by the human eye’s rejection of alloplastic artificial corneas. Additionally, because artificial cornea implant surgery is expensive. It is not widely used in developing countries. Which will restrain market expansion during the forecast period. The global market has also been greatly influenced by the lack of human cornea donors. And the high risk of grafting artificial cornea implants.
Opportunity
Corneal implant manufacturers will offer high growth potential. Due to the high prevalence of corneal blindness and the shortage of corneal donors. Furthermore, the artificial cornea implant market is anticipated to grow significantly due to the increasing prevalence of corneal infections. Additionally, the rising visual impairments among working people caused by cloudy corneas have increased demand for these corneal implants on the global market.
Market Segmentation
By Implantation Type
Based on the Implantation Type, the penetrating keratoplasty segment holds most of the market. Due to an increase in patients suffering from eye diseases like infectious keratitis and eyeball injuries. Penetrating keratoplasty has become more popular.
By Type
The “human cornea” segment ruled the market with the largest revenue share. Particularly in emerging nations, this market segment will raise awareness regarding corneal implantation and tissue donation.
By Disease Manifestation
Fuchs dystrophy segment ruled the entire market with maximum revenue share. This market will grow quickly because of the rising prevalence of eye-related disorders. And growing public awareness of the importance of early diagnosis.
By End-User
The specialty clinics segment ruled the entire market. This market’s growth is influenced by the drop in inpatient surgeries. And the rising popularity of less invasive procedures. Concerns regarding hospital acquired infections and patient desires for effective treatment are driving this segment’s growth. The majority of ambulatory surgical facilities over synthetic ones prefer biosynthetic cornea implants.
Regional Overview
North America maintained the largest position in the regional market. It is due to the region’s advanced healthcare infrastructure. Growing adoption of cutting-edge medical technology, and a wide variety of corneal implant manufacturers. Furthermore, Asia-Pacific will develop the fastest during the forecast period due to the region’s vast population base, rising disposable income, and growing patient awareness of eye care.
Key Players
- Cornea Biosciences
- SightLife
- San Diego Eye Bank
- DIOPTEX GmbH
- Massachusetts Eye and Ear
- Advancing Sight Network
- EyeYon Medical
- Aurolab
- PresbiaPlc
- Florida Lions Eye Bank
- Mediphacos
- Addition Technology
- LinkoCare Life Sciences AB
- AJL Ophthalmics
The market worth of artificial cornea and corneal implants in 2021 was worth USD 421 million. And by 2030 it will be worth USD 6.9% CAGR during the forecast period. The market for artificial cornea and corneal implants is expanding. Due to the rise in ophthalmic conditions such as Fuchs dystrophy, keratoconus. And viral keratitis, as well as consumer desire to spend more on eye care.
“One of the upsides of a counterfeit cornea is that it can assist with reestablishing vision in patients who are bad contender professionally corneal transfer from a human giver,” said Dr. Cost. “The achievement pace of corneal transfers has expanded extraordinarily throughout recent years, yet there are a few circumstances where human contributor transfers don’t work.